Objectives: This is an introduction to the sponsored seminar.

Introduction: This is an introduction to the sponsored seminar.

Materials / method: This is an introduction to the sponsored seminar.

Results: This is an introduction to the sponsored seminar.

Conclusion: This is an introduction to the sponsored seminar.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: To study the efficacy and safety of a single treatment using MFU-V and CaHA+ in the treatment of striae distensae albae (SDA) in Asian women

Introduction: There are many modalities to treat SDA but there is no one treatment modality that can provide significant improvement. Current practice is a combination treatment approach and require multiple sessions. There is an unmet need to find a single combination treatment that is safe and effective in treating SDA in Asian patients

Materials / method: 10 consecutive women with SDA were enrolled in the study. The SDA were treated in a single treatment using a combination treatment of MFU-V and diluted calcium hydroxyapatite. Evaluation was done at 1,3, 6 months after the treatment using clinical photographs, a SDA scale, VAS, GAIS and patient's satisfaction scale. Any side-effects were also noted

Results: At 3 months, all patients had a mild improvement (<25%). By 6 months 8 patients had a moderate-good improvement (25-50%) and 2 had good improvement (51-75%). Adverse events were uncommon, with 2 having bruises from the injection and these were self-limiting. All patient reported improvement in their SDA and were either satisfied or very satisfied with their treatments.

Conclusion: A single combination treatment of MFU-V and diluted calcium hydroxyapatite is safe and effective in treating SDA in Asian women

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: Can single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement?

Introduction: Standard lifting and tightening protocols with microfocused ultra- sound with visualization (MFU-V, Ultherapy) comprise the use of multiple transducer depths. We developed a shortened, single depth treatment protocol for patients seeking skin rejuvenation.

Materials / method: Single-center, prospective case series. Subjects with static periorbital wrinkles, perioral wrinkles, or accordion lines had a single MFU-V treatment com- prising up to 340 lines (periorbital 120, perioral 100, and accordion 120) with the superficial depth transducer (10.0 MHz/1.5mm). Efficacy was assessed using established rating scales as well as clinician- and subject-reported Global Aesthetic Improvement Scales at baseline, 90, and 180 days, and each subject served as their own control. Adverse events were documented.

Results: Nine subjects, women aged 38–64, received treatment. At 180 days, post treatment clinicians reported visible improvements in periorbital lines (6/6 cases), accordion lines (5/6 cases), and perioral lines (3/6 cases). Subjects’ self-assess- ments mirrored those of the clinicians, reporting improvements in accordion lines (5/6 cases improved, 1/6 cases much improved), periorbital lines (3/6 cases improved, 3/6 cases much improved) and perioral lines (2/6 cases improved, 2/6 cases much improved). Subject-rated satisfaction was high (accordion lines 6/6 cases, periorbital lines 4/6 cases

Conclusion: Shortened protocol, single depth MFU-V treatment was well tolerated. It provided aesthetic improvements in periorbital and accordion lines, and to a lesser extent in perioral lines. Its utility as a noninvasive therapy for superficial skin rejuvenation warrants further investigation.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: To compare the efficacy of MFU-V monotherapy and MFU-V combined with L-HA injection for the treatment of enlarged facial pores in Asians.

Introduction: Enlarged facial pores are a common cosmetic complaint among people around the world. Microfocused ultrasound with visualization (MFU-V) has been shown to improve the appearance of facial pores. Low-degree cross-linked hyaluronic acid filler (L-HA) injection has recently become a popular procedure for skin rejuvenation. Nevertheless, the effectiveness of the combination of MFU-V and L-HA injection in the treatment of enlarged pores has not been evaluated.

Materials / method: We conducted a randomized, single-blinded, split-face study on participants with enlarged facial pores. Each side of the face was randomly assigned to treatment with a single session of MFU-V or combined MFU-V with L-HA injection. Pore volume was objectively measured by an Antera 3D system. Subjective assessment was evaluated by one-blinded physician using a pore grading score (0-4). Patients also rated the improvement in terms of satisfaction using the visual analog scale (VAS, 0-10).

Results: Forty-six participants completed the study. Overall, the mean pore volume of both sides declined with statistical significance at every visit compared to baseline, with the lowest mean at 4 months post treatment. The combined MFU-V with L-HA injection showed a lower mean pore volume than MFU-V monotherapy throughout the follow-ups. Physicians subjectively evaluated the pores using visual grading scores. However, there was no statistically significant difference between the two techniques. The patient satisfaction score showed a similar trend to the mean pore volume, with a statistically signif

Conclusion: MFU-V monotherapy and MFU-V combined with L-HA injection can effectively and safely minimize enlarged facial pores. The combined technique resulted in more patient satisfaction.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。